PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31234327-1	2019	The role of glucosylsphingosine (lyso-Gb1), a downstream metabolic product of glucosylceramide, for monitoring treated and untreated children with Gaucher disease (GD) has not yet been studied.	Glucosylceramides	78-94	gamma-aminobutyric acid type B receptor subunit 1	Homo sapiens	38-41	
28851512-2	2017	Lyso-Gb1 (glucosylsphingosine, lyso-GL1), a downstream metabolic product of glucosylceramide, has been identified as a promising biomarker for the diagnosis and monitoring of patients with GD.	Glucosylceramides	76-92	gamma-aminobutyric acid type B receptor subunit 1	Homo sapiens	5-8